Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTD1801 in Type 2 Diabetes Mellitus
NCT06411275Phase 2Completed
- Sponsor
- HighTide Therapeutics, Inc.
- Start
- Mar 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of berberine ursodeoxycholate in type 2 diabetes mellitus (T2DM), sponsored by HighTide Therapeutics, Inc.. Started Mar 2022; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06411275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411275.